Patents Assigned to Bringham and Women's Hospital
-
Patent number: 11367179Abstract: Systems and techniques for determining degree of motion using machine learning to improve medical image quality are presented. In one example, a system generates, based on a convolutional neural network, motion probability data indicative of a probability distribution of a degree of motion for medical imaging data generated by a medical imaging device. The system also determines motion score data for the medical imaging data based on the motion probability data.Type: GrantFiled: September 30, 2019Date of Patent: June 21, 2022Assignees: GE Precision Healthcare LLC, Partners Healthcare System, Inc., The General Hospital Corporation, The Bringham and Women's Hospital, Inc.Inventors: Jason Polzin, Bernardo Bizzo, Bradley Wright, John Kirsch, Pamela Schaefer
-
Patent number: 10682392Abstract: In some aspects, the invention teaches pharmaceutical compositions that include a TGF-beta ligand trap, and methods of using a TGF-beta ligand trap to treat, prevent, or reduce the progression rate of pulmonary hypertension (PH). The invention also provides methods of using a TGF-beta ligand trap to treat, prevent, or reduce the progression rate of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, right ventricular hypertrophy, diseases associated with excessive TGF-beta signaling, diseases associated with excessive GDF15 signaling, and diseases associated with excessive PAI-1 signaling. The invention further provides methods of using a TGF-beta ligand trap to reduce right ventricular systolic pressure in a subject.Type: GrantFiled: November 21, 2014Date of Patent: June 16, 2020Assignees: THE BRINGHAM AND WOMEN'S HOSPITAL, INC., ACCELERON PHARMA, INC.Inventors: Paul Yu, Asya Grinberg, Dianne S. Sako, Roselyne Castonguay, Rita Steeves, Ravindra Kumar
-
Patent number: 10430933Abstract: Method and system for lensless, shadow optical imaging. Formation of a hologram shadow image having higher spatial resolution and lower noise level is accomplished by processing image information contained in multiple individual hologram shadow image frames acquired either under conditions of relative shift between point light source and the detector of the system or under stationary conditions, when system remains fixed in space and is devoid of any relative movement during the process of acquisition of individual image frames.Type: GrantFiled: February 25, 2016Date of Patent: October 1, 2019Assignee: The Bringham and Women's Hospital, Inc.Inventors: Antonio Carlos Sobieranski, Utkan Demirci, Huseyin Cumhur Tekin, Fatih Inci
-
Patent number: 7786255Abstract: The present invention relates to peptides, particularly human monoclonal antibodies, that bind specifically to poly-N-acetyl glucosamine (PNAG), such as Staphylococcal PNAG, in acetylated, partially acetylated and/or fully deacetylated form. The invention further provides methods for using these peptides in the diagnosis, prophylaxis and therapy of infections by bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Some antibodies of the invention enhance opsonophagocytic killing and in vivo protection against bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Compositions of these peptides, including pharmaceutical compositions, are also provided, as are functionally equivalent variants of such peptides.Type: GrantFiled: April 21, 2005Date of Patent: August 31, 2010Assignees: The Bringham and Women's Hospital, Inc., Beth Israel Deaconess Medical Center, Inc.Inventors: Gerald B. Pier, Casie Anne Kelly-Quintos, Lisa Cavacini, Marshall R. Posner
-
Patent number: 6750360Abstract: Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.Type: GrantFiled: March 9, 2001Date of Patent: June 15, 2004Assignee: Bringham and Women's HospitalInventor: Charles N. Serhan
-
Patent number: 6579313Abstract: A method for implanting cells onto a prosthesis includes the steps of: (a) providing a prosthesis including a porous tube, where at least 25% of the pores on the inner surface of the tube have diameters of more than about 40 &mgr;m, at least 25% of the pores on the outer surface of the tube have diameters of less than about 30 &mgr;m, and the tube includes a substantially continuous layer of a biocompatible material; (b) contacting the prosthesis with a suspension of cells; and (c) providing a pressure differential between the inner surface and the outer surface, whereby the cells are retained in the pores of the inner surface. A method for obtaining an endothelial cell culture from a blood sample involved:(a) obtaining a sample for mononuclear cells from a blood sample; and (b) culturing the sample of mononuclear cells, without further cell separation, on a cell adhesive polymer-coated solid support in the presence of endothelial growth factors.Type: GrantFiled: January 18, 2002Date of Patent: June 17, 2003Assignee: The Bringham and Women's HospitalInventors: Victor J. Dzau, Richard E. Pratt, Michael J. Mann, Afshin Ehsan, Daniel P. Griese
-
Patent number: 5912121Abstract: The invention pertains to methods for detecting the presence or absence of a mutation associated with hypertrophic cardiomyopathy (HC). The methods include providing DNA which encodes a sarcomeric thin filament protein (e.g., .alpha.-tropomyosin or cardiac troponin T) and detecting the presence or absence of a mutation in the amplified product which is associated with HC. DNA encoding an actin-associated protein, a myosin-associated protein, or a sarcomeric protein other than .beta. cardiac heavy chain can also be used in the methods of the present invention. The invention further pertains to methods for diagnosing familial HC (FHC) in a subject. These methods typically include obtaining a sample of DNA which encodes a sarcomeric thin filament protein from a subject being tested for FHC and diagnosing the subject for FHC by detecting the presence or absence of a mutation in the sarcomeric thin filament protein which causes FHC as an indication of the disease.Type: GrantFiled: December 12, 1994Date of Patent: June 15, 1999Assignees: Bringham and Women's Hospital, President and Fellows of Harvard CollegeInventors: Christine Seidman, Jonathan Seidman, Ludwig Thierfelder, Hugh Watkins, Calum McRae